PT1301192E - Utilização de ciclodextrinas polissulfatadas para o tratamento de artrose - Google Patents

Utilização de ciclodextrinas polissulfatadas para o tratamento de artrose Download PDF

Info

Publication number
PT1301192E
PT1301192E PT01954083T PT01954083T PT1301192E PT 1301192 E PT1301192 E PT 1301192E PT 01954083 T PT01954083 T PT 01954083T PT 01954083 T PT01954083 T PT 01954083T PT 1301192 E PT1301192 E PT 1301192E
Authority
PT
Portugal
Prior art keywords
treating osteoarthritis
polysulphated
cyclodextrins
polysulphated cyclodextrins
osteoarthritis
Prior art date
Application number
PT01954083T
Other languages
English (en)
Inventor
Eric Maximilien Veys
August Lodewijk Verbruggen
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Publication of PT1301192E publication Critical patent/PT1301192E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT01954083T 2000-07-17 2001-07-12 Utilização de ciclodextrinas polissulfatadas para o tratamento de artrose PT1301192E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0009272A FR2811572B1 (fr) 2000-07-17 2000-07-17 Utilisation de cyclodextrines polysulfatees pour le traitement de l'arthrose

Publications (1)

Publication Number Publication Date
PT1301192E true PT1301192E (pt) 2009-04-24

Family

ID=8852528

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01954083T PT1301192E (pt) 2000-07-17 2001-07-12 Utilização de ciclodextrinas polissulfatadas para o tratamento de artrose

Country Status (13)

Country Link
US (1) US6930098B2 (pt)
EP (1) EP1301192B1 (pt)
JP (1) JP4960568B2 (pt)
AT (1) ATE421326T1 (pt)
AU (1) AU2001276437A1 (pt)
CA (1) CA2416369C (pt)
CY (1) CY1108980T1 (pt)
DE (1) DE60137506D1 (pt)
DK (1) DK1301192T3 (pt)
ES (1) ES2322794T3 (pt)
FR (1) FR2811572B1 (pt)
PT (1) PT1301192E (pt)
WO (1) WO2002005826A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7988962B2 (en) 2003-12-02 2011-08-02 Universiteit Gent Use of polysulphated alginate in cellular matrices
US8466278B2 (en) * 2008-09-22 2013-06-18 Arcarios B.V. Carboxyethylated cyclodextrin polysulfates useful as medicaments
US20130046087A1 (en) 2010-03-24 2013-02-21 Arcarios Bv Substituted Cyclodextrin Derivatives Useful As Intermediates For Producing Biologically Active Materials
ITMI20132116A1 (it) 2013-12-18 2015-06-19 Apharm Srl Associazione di glicosamminoglicani e ciclodestrine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4258180A (en) * 1979-11-05 1981-03-24 American Cyanamid Company C6-Modified cyclodextrin sulfate salts as complement inhibitors
US4247535A (en) * 1979-11-05 1981-01-27 American Cyanamid Company Modified cyclodextrin sulfate salts as complement inhibitors
EP0325199B1 (en) * 1988-01-19 1993-10-27 Takeda Chemical Industries, Ltd. Fumagillin as angiostatic agent
EP0447171B1 (en) * 1990-03-15 1994-11-02 Tanabe Seiyaku Co., Ltd. Polysulfate of cyclodextrin derivative and process for preparing the same
US5100878A (en) * 1990-05-07 1992-03-31 American Maize-Products Company Blocking the effect of teratogens on a fetus
CA2101630A1 (en) * 1991-01-30 1992-07-31 Werner Thorwart Niedermolekulare sulfatierte poly-.beta.-2,6-fructofuranosane und deren verwendung zur behandlung von degenerativen gelenkserkrankungen ( low molecular sulphated poly-.beta.-2,6 fructofuranosanes and their use in the treatment of degenerati e articular ailments)
BR9206736A (pt) * 1991-11-11 1995-10-31 Univ Pennsylvania Composição para afetar o crescimento de tecido vivo em mamíferos processos para promover a angiogenese em mamíferos para tratar tecido transplantado ou órgãos em mamíferos e para tratar osso danificado ou transplantado
US5872109A (en) * 1995-02-07 1999-02-16 Shiseido Company, Ltd. Anti-inflammatory agent
US5843920A (en) * 1996-09-16 1998-12-01 Biocell Technology, Llc Anionic saccharides for extraction of anti-angiogenic protein from cartilage

Also Published As

Publication number Publication date
EP1301192B1 (fr) 2009-01-21
JP4960568B2 (ja) 2012-06-27
CA2416369A1 (fr) 2002-01-24
DK1301192T3 (da) 2009-05-18
AU2001276437A1 (en) 2002-01-30
ATE421326T1 (de) 2009-02-15
JP2004503594A (ja) 2004-02-05
WO2002005826A1 (fr) 2002-01-24
DE60137506D1 (de) 2009-03-12
CY1108980T1 (el) 2014-07-02
US6930098B2 (en) 2005-08-16
ES2322794T3 (es) 2009-06-29
FR2811572B1 (fr) 2003-04-18
CA2416369C (fr) 2008-07-15
EP1301192A1 (fr) 2003-04-16
US20030109493A1 (en) 2003-06-12
FR2811572A1 (fr) 2002-01-18

Similar Documents

Publication Publication Date Title
PT1420801E (pt) Utilização de fucanos no tratamento de adesões, artrite e psoríase
WO2005055944A3 (en) Oligosaccharide compositions and use thereof in the treatment of infection
RS49756B (sr) Primena ksenona ili smeša ksenonskog gasa za proizvodnju farmaceutskog preparata za lečenje neurointoksikacija
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
TW200510416A (en) P38 inhibitors and methods of use thereof
PT1411908E (pt) Tratamento de infeccoes da unha com no
PL349028A1 (en) Cancer treatment composition and method using natural plant essential oils
HK1085140A1 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
MY133732A (en) Sulfonylcarboxamide derivatives, process for their preparation and their use as medicines
MXPA05011886A (es) Metodos y composiciones para la prevencion y tratamiento de septicemia.
DE60118547D1 (de) Pharmazeutische zusammensetzung zur behandlung von kolorektalem krebs welche thalidomid und irinotecan enthält
TW200509949A (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
WO2003106384A3 (en) NOVEL BORIC CHALCONE DERIVATIVES AND USES THEREOF
ATE334690T1 (de) Zusammensetzungen zur behandlung von bindegeweben,die ein eisen(ii)-ion und ascorbat enthalten
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
CY1108980T1 (el) Χρηση πολυσουλφωμενων κυκλοδεξτρινων για τη θεραπεια της αρθριτιδας
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
WO2001015677A3 (en) Use of 5-ht1b/1d agonists to treat otic pain
AU5548801A (en) Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
BR0111785A (pt) Composições e métodos para tratamento de candidìase
ATE274513T1 (de) Verbindungen und verfahren zur behandlung von schmerz
EP1546377A4 (en) METHODS AND COMPOSITIONS FOR TREATING PAIN AND PAIN DISORDERS USING MOLECULES 9949, 14230, 760, 62553, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 9569 OR 13424
TW200508196A (en) Hydroxamic acids useful in the treatment of hyper-proliferative disorders